Literature DB >> 92572

Preparation of syngeneic tumor regressor serum reactive with the unique determinants of the Abelson murine leukemia virus-encoded P120 protein at the cell surface.

O N Witte, N Rosenberg, D Baltimore.   

Abstract

Antisera reactive with the Abelson murine leukemia virus (A-MuLV)-specified P120 (anti-AbT sera) were produced in C57L/J mice. Of many strains tested, only C57L/J reproducibly rejected syngenic A-MuLV-induced tumor cells; after multiple immunizations their sera would immunoprecipitate both P120 and Moloney-MuLV (M-MuLV) proteins. Using labeled A-MuLV-induced nonproducer cells, only P120 could be detected by anti-AbT sera, suggesting that it may be the only A-MuLV-specified protein. Reactivity of anti-AbT sera with P120 was not blocked by M-MuLV virion proteins, implying that the sera recognize a portion of P120 that is not homologous to any M-MuLV product. Anti-AbT sera stained the surface of live, A-MuLV-transformed nonproducer cells in a two-stage immunofluorescence assay, and such staining was not blocked by M-MuLV protein. Also, intact A-MuLV-transformed cells absorbed much of the reactivity of certain anti-AbT sera for P120. Thus a portion of P120 appears to be exposed on the surface of transformed cells. P120 lacks detectable carbohydrate, is not affected by endoglycosidase H, and cannot be labeled by lactoperoxidase-catalyzed iodination. Thus P120 is an unusual surface protein.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 92572      PMCID: PMC353505     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Transplantation and preliminary characterisation of lymphocyte surface markers of Abelson virus-induced lymphomas.

Authors:  M D Sklar; E M Shevach; I Green; M Potter
Journal:  Nature       Date:  1975-02-13       Impact factor: 49.962

3.  Direct transformation of 3T3 cells by Abelson murine leukaemia virus.

Authors:  C D Scher; R Siegler
Journal:  Nature       Date:  1975-02-27       Impact factor: 49.962

4.  In vitro transformation of lymphoid cells by Abelson murine leukemia virus.

Authors:  N Rosenberg; D Baltimore; C D Scher
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

5.  Synthesis, surface deposition, and secretion of immunoglobulins by Abelson virus-transformed lymphosarcoma cell lines.

Authors:  E Premkumar; M Potter; P A Singer; M D Sklar
Journal:  Cell       Date:  1975-10       Impact factor: 41.582

6.  Oncornavirus budding: kinetics of formation and utilization of viral membrane glycoprotein.

Authors:  O N Witte; I L Weissman
Journal:  Virology       Date:  1976-02       Impact factor: 3.616

7.  Identification of a transformation-specific antigen induced by an avian sarcoma virus.

Authors:  J S Brugge; R L Erikson
Journal:  Nature       Date:  1977-09-22       Impact factor: 49.962

8.  Feline oncornavirus-associated cell membrane antigen: evidence for an immunologically crossreactive feline sarcoma virus-coded protein.

Authors:  J R Stephenson; A S Khan; A H Sliski; M Essex
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Abelson virus-transformed lymphocytes: null cells that modulate H-2.

Authors:  D M Pratt; J Strominger; R Parkman; D Kaplan; J Schwaber; N Rosenberg; C D Scher
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

10.  The effect of helper virus on Abelson virus-induced transformation of lymphoid cells.

Authors:  N Rosenberg; D Baltimore
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

View more
  44 in total

1.  Mutation of Tp53 contributes to the malignant phenotype of Abelson virus-transformed lymphoid cells.

Authors:  K C Thome; A Radfar; N Rosenberg
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  bcr/abl and src but not myc and ras replace v-abl in lymphoid transformation.

Authors:  A Engelman; N Rosenberg
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

3.  Abelson murine leukemia virus-transformed cells that lack p53 protein synthesis express aberrant p53 mRNA species.

Authors:  D Wolf; S Admon; M Oren; V Rotter
Journal:  Mol Cell Biol       Date:  1984-03       Impact factor: 4.272

4.  Comparison of phosphorylation of two polyoma virus middle T antigens in vivo and in vitro.

Authors:  B Schaffhausen; T L Benjamin
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

5.  Detection of the v-abl gene product at cell-substratum contact sites in Abelson murine leukemia virus-transformed fibroblasts.

Authors:  L R Rohrschneider; L M Najita
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

6.  Avian myeloblastosis virus and E26 virus oncogene products are nuclear proteins.

Authors:  W J Boyle; M A Lampert; J S Lipsick; M A Baluda
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

7.  Only site-directed antibodies reactive with the highly conserved src-homologous region of the v-abl protein neutralize kinase activity.

Authors:  J B Konopka; R L Davis; S M Watanabe; A S Ponticelli; L Schiff-Maker; N Rosenberg; O N Witte
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

8.  A transformation-defective mutant of Abelson murine leukemia virus lacks protein kinase activity.

Authors:  O N Witte; S Goff; N Rosenberg; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

9.  Transfection of fibroblasts by cloned Abelson murine leukemia virus DNA and recovery of transmissible virus by recombination with helper virus.

Authors:  S P Goff; C J Tabin; J Y Wang; R Weinberg; D Baltimore
Journal:  J Virol       Date:  1982-01       Impact factor: 5.103

10.  Loss of viral gene expression and retention of tumorigenicity by Abelson lymphoma cells.

Authors:  D J Grunwald; B Dale; J Dudley; W Lamph; B Sugden; B Ozanne; R Risser
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.